Abstract:In recent years, the application of advanced analytics, especially artificial intelligence (AI), to digital H&E images, and other histological image types, has begun to radically change how histological images are used in the clinic. Alongside the recognition that the tumour microenvironment (TME) has a profound impact on tumour phenotype, the technical development of highly multiplexed immunofluorescence platforms has enhanced the biological complexity that can be captured in the TME with high precision. AI has an increasingly powerful role in the recognition and quantitation of image features and the association of such features with clinically important outcomes, as occurs in distinct stages in conventional machine learning. Deep-learning algorithms are able to elucidate TME patterns inherent in the input data with minimum levels of human intelligence and, hence, have the potential to achieve clinically relevant predictions and discovery of important TME features. Furthermore, the diverse repertoire of deep-learning algorithms able to interrogate TME patterns extends beyond convolutional neural networks to include attention-based models, graph neural networks, and multimodal models. To date, AI models have largely been evaluated retrospectively, outside the well-established rigour of prospective clinical trials, in part because traditional clinical trial methodology may not always be suitable for the assessment of AI technology. However, to enable digital pathology-based advanced analytics to meaningfully impact clinical care, specific measures of 'added benefit' to the current standard of care and validation in a prospective setting are important. This will need to be accompanied by adequate measures of explainability and interpretability. Despite such challenges, the combination of expanding datasets, increased computational power, and the possibility of integration of pre-clinical experimental insights into model development means there is exciting potential for the future progress of these AI applications. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Emerging role of deep learning-based artificial intelligence in tumor pathology

Emerging Role of Deep Learning‐based Artificial Intelligence in Tumor Pathology

Deep Learning in Digital Pathology Analysis

Role of artificial intelligence in digital pathology for gynecological cancers

Progress on deep learning in digital pathology of breast cancer: a narrative review

Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine

Application and Research Progress of Artificial Intelligence in Digital Pathological Image Analysis of Colorectal Cancer

Artificial intelligence in digital histopathology for predicting patient prognosis and treatment efficacy in breast cancer

AI in Computational Pathology of Cancer: Improving Diagnostic Workflows and Clinical Outcomes?

Multi-modality artificial intelligence in digital pathology

Artificial Intelligence for Digital and Computational Pathology

Artificial intelligence in diagnostic pathology

Application of digital pathology-based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response

Advancements in computer vision and pathology: Unraveling the potential of artificial intelligence for precision diagnosis and beyond

Artificial intelligence: illuminating the depths of the tumor microenvironment

Artificial intelligence's impact on breast cancer pathology: a literature review

Deep learning in cancer pathology: a new generation of clinical biomarkers

Artificial Intelligence and Its Applications in Digital Hematopathology

Advances in Artificial Intelligence-assisted Diagnosis of Malignant Tumors

The State of Applying Artificial Intelligence to Tissue Imaging for Cancer Research and Early Detection